Oxbridge Re (NASDAQ:OXBR – Get Free Report) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Tuesday,Zacks.com reports.
Several other brokerages have also recently commented on OXBR. Maxim Group reduced their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a report on Tuesday, June 16th. Weiss Ratings raised shares of Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Friday, August 14th. One research analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $3.00.
Get Our Latest Research Report on Oxbridge Re
Oxbridge Re Price Performance
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The insurance provider reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). The business had revenue of $0.94 million for the quarter, compared to analyst estimates of $1.10 million. Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%. As a group, research analysts anticipate that Oxbridge Re will post -0.08 earnings per share for the current year.
Institutional Investors Weigh In On Oxbridge Re
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. International Assets Investment Management LLC boosted its stake in Oxbridge Re by 61.2% in the first quarter. International Assets Investment Management LLC now owns 48,000 shares of the insurance provider’s stock valued at $54,000 after buying an additional 18,227 shares in the last quarter. J.W. Cole Advisors Inc. raised its position in Oxbridge Re by 106.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after purchasing an additional 35,000 shares during the last quarter. Finally, Virtu Financial LLC bought a new position in shares of Oxbridge Re during the third quarter worth about $32,000. 5.64% of the stock is currently owned by institutional investors.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Read More
- Five stocks we like better than Oxbridge Re
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
